Literature DB >> 22867784

Financial risk-sharing in updating the National List of Health Services in Israel: stakeholders' perceived interests.

Ariel Hammerman1, Paula Feder-Bubis, Dan Greenberg.   

Abstract

OBJECTIVES: Risk-sharing is being considered by many health care systems to address the financial risk associated with the adoption of new technologies. We explored major stakeholders' views toward the potential implementation of a financial risk-sharing mechanism regarding budget-impact estimates for adding new technologies to the Israeli National List of Health Services. According to our proposed scheme, health plans will be partially compensated by technology sponsors if the actual use of a technology is substantially higher than what was projected and health plans will refund the government for budgets that were not fully utilized.
METHODS: By using a semi-structured protocol, we interviewed major stakeholders involved in the process of updating the National List of Health Services (N = 31). We inquired into participants' views toward our proposed risk-sharing mechanism, whether the proposed scheme would achieve its purpose, its feasibility of implementation, and their opinion on the other stakeholders' incentives.
RESULTS: Participants' considerations were classified into four main areas: financial, administrative/managerial, impact on patients' health, and influence on public image. Most participants agreed that the conceptual risk-sharing scheme will improve the accuracy of early budget estimates and were in favor of the proposed scheme, although Ministry of Finance officials tended to object to it.
CONCLUSIONS: The successful implementation of risk-sharing schemes depends mainly on their perception as a win-win situation by all stakeholders. The perception exposed by our participants that risk-sharing can be a tool for improving the accuracy of early budget-impact estimates and the challenges pointed by them are relevant to other health care systems also and should be considered when implementing similar schemes.
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22867784     DOI: 10.1016/j.jval.2012.01.007

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  3 in total

1.  Impact of a financial risk-sharing scheme on budget-impact estimations: a game-theoretic approach.

Authors:  Arieh Gavious; Dan Greenberg; Ariel Hammerman; Ella Segev
Journal:  Eur J Health Econ       Date:  2013-12-11

2.  Country versus pharmaceutical company interests for hepatitis C treatment.

Authors:  Roy Lothan; Noa Gutman; Dan Yamin
Journal:  Health Care Manag Sci       Date:  2022-08-24

3.  Oncologists' and family physicians' views on value for money of cancer and congestive heart failure care.

Authors:  Dan Greenberg; Ariel Hammerman; Shlomo Vinker; Adi Shani; Yuval Yermiahu; Peter J Neumann
Journal:  Isr J Health Policy Res       Date:  2013-11-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.